Skip to main content
Premium Trial:

Request an Annual Quote

Telechem International, Integrated Media Holdings, Nanostring Technologies, Baylor College of Medicine

Telechem Merges with Publicly Traded Communications Firm in $23M Deal
Telechem International, the microarray and scanner manufacturer also known as Arrayit, has signed a definitive agreement to merge with publicly traded digital communications firm Integrated Media Holdings in a deal worth roughly $23.1 million.
Houston-based Integrated Media Holdings currently trades on the OTC Bulletin Board, and at the close of the market yesterday traded at $.022 per share. However, IMH’s board has approved a 1-for-30 reverse split of the stock, which would up its price to $.66 per share.
IMH agreed to acquire Telechem in exchange for 35 million post-split shares, which gives the transaction a value of $23.1 million. As a result of the merger, shareholders of privately held Telechem will own 64.95 percent of the outstanding shares of the merged company.
It is unclear whether the combined entity will retain IMH’s name or Telechem’s name.
“We believe this will enhance our ability to access capital and further the growth strategy as a leader in the biotech niche we serve,” Rene Schena, CEO of Sunnyvale, Calif.-based Telechem, said in a statement.
Schena said that being public has been “a long-term goal of the company” and that Telechem will be unveiling its strategic plan over the next few weeks.
As a public company, our plans and funding potential opportunities are confidential,” Schena said. “We are very optimistic, and once our story is told, we believe our stock will be appropriately valued."
Telechem declined to answer further questions about the merger.

Baylor, Miami to Use Nanostring’s Barcode Gene-Expression Systems
Nanostring Technologies has placed two of its barcode-based gene expression-analysis systems in research labs at the University of Miami’s Miller School of Medicine and at the Baylor College of Medicine, the company said this week.
The Seattle, Wash.-based company said that the two Early Access nCounter Analysis Systems will be the final instruments sold before it launches its commercial marketing program this week at the Association for Biomolecular Research Facilities conference in Salt Lake City. The firm noted that it is currently taking orders for the systems.
Under the early-access program, the systems will be used at the Baylor College of Medicine’s Microarray Core Facility in Houston and at the Sylvester Comprehensive Cancer Center at Miami’s Miller School of Medicine.
The company’s digital barcode technology uses single molecule imaging to detect and count unique transcripts in a single reaction. The company said it is suited for researchers who are working with “small amounts of starting material or studying defined gene sets.”
Financial terms of the agreements were not released.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.